Hildegard Keppeler - University Clinic of Tuebingen

基本信息

浏览量：11

职业迁徙

个人简介

Hildegard Keppeler currently works at the Department of Internal Medicine II, University of Tuebingen. Hildegard does research in Clinical Immunology, Haematology and Oncology.

研究兴趣

论文共 104 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

PD-1 Checkpoint Inhibition Enhances the Antilymphoma Activity of CD19-CAR-iNKT Cells That Retain Their Ability to Prevent Alloreactivity

Emmanuelle Moraes Ribeiro,Kathy-Ann Secker, Ana-Maria Nitulescu,Rebekka Schairer,Hildegard Keppeler, Anton Wesle,Hannes Schmid,Anita Schmitt,Brigitte Neuber,Daniela Chmiest, Silvia Podavini,Melanie Maerklin,Boris Klimovich,Michael Schmitt,Fulya Korkmaz,Claudia Lengerke,Corina Schneidawind,Dominik Schneidawind

JOURNAL FOR IMMUNOTHERAPY OF CANCERno. 1 (2024)

引用0浏览0WOS引用

CD19-CAR-iNKT cells transactivate NK cells and reduce alloreactivity

Anton Wesle,Emmanuelle Moraes Ribeiro,Rebekka Schairer,Hildegard Keppeler,Fulya Korkmaz, Pia Radszuweit,Kristin Bieber,Claudia Lengerke,Dominik Schneidawind,Corina Schneidawind

Cytotherapy (2024)

引用0浏览0引用

CD19-chimeric Antigen Receptor-Invariant Natural Killer T Cells Transactivate NK Cells and Reduce Alloreactivity

Anton Wesle,Emmanuelle Moraes Ribeiro,Rebekka Schairer,Hildegard Keppeler,Fulya Korkmaz, Pia Radszuweit,Kristin Bieber, Claudia Lengerke,Dominik Schneidawind,Corina Schneidawind

Cytotherapy (2024)

引用0浏览0WOS引用

Treatment Response of Advanced HNSCC Towards Immune Checkpoint Inhibition is Associated with an Activated Effector Memory T Cell Phenotype

Max Schumacher, Sina Beer,Emmanuelle Moraes Ribeiro,Fulya Korkmaz,Hildegard Keppeler,Rahel Fitzel,Estelle Erkner, Pia Radszuweit,Claudia Lengerke,Corina Schneidawind,Sebastian Hoefert, Paul Stefan Mauz,Dominik Schneidawind

FRONTIERS IN ONCOLOGY（2024）

引用0浏览0WOS引用

The Rorɣ/SREBP2 Pathway is a Master Regulator of Cholesterol Metabolism and Serves As Potential Therapeutic Target in T(4;11) Leukemia

Estelle Erkner,Thomas Hentrich,Rebekka Schairer,Rahel Fitzel, Kathy-Ann Secker-Grob,Johan Jeong,Hildegard Keppeler,Fulya Korkmaz,Julia M. Schulze-Hentrich,Claudia Lengerke,Dominik Schneidawind,Corina Schneidawind

ONCOGENE（2024）

引用0浏览0WOSNATURE引用

Expression von immunreaktiven NKG2DL in der gesunden und malignen Hamatopoese

H. Landerer,H. Keppeler,R. Fitzel,E. Erkner,C. Schneidawind,S. Rudat,C. Lengerke

ONCOLOGY RESEARCH AND TREATMENT (2023): 135-135

引用0浏览0引用

Effects of Single or Combinational Doxorubicin Treatment in Cul3/p53 Ko Cells from Inducing Differentiation of Premalignant Hepatic Cells As a Novel Therapeutic Strategy in Hepatocarcinoma

Benita Wolf, Kathrin Krieg,Christine Falk,Kai Breuhahn,Hildegard Keppeler,Tilo Biedermann, Evi Schmid,Steven Warmann,Joerg Fuchs,Silvia Vetter,Dennis Thiele, Maike Nieser,Meltem Avci-Adali,Yulia Skokowa, Ludger Schöls, Stefan Hauser,Marc Ringelhan,Tetyana Yevsa,Mathias Heikenwalder,Uta Kossatz-Boehlert

openalex（2023）

引用0浏览0引用

Targeting MYC in Combination with Epigenetic Regulators Induces Synergistic Anti-Leukemic Effects in MLLr Leukemia and Simultaneously Improves Immunity

Rahel Fitzel, Kathy-Ann Secker-Grob,Hildegard Keppeler,Fulya Korkmaz,Rebekka Schairer,Estelle Erkner,Dominik Schneidawind,Claudia Lengerke,Thomas Hentrich,Julia M. Schulze-Hentrich,Corina Schneidawind

Neoplasia (2023): 100902-100902

引用2浏览0WOS引用

Pd-1 checkpoint inhibition improves functionality of tolerogenic cd19-car-inkt cells against cd19+malignancies

Emmanuelle Moraes Ribeiro, Anton Wesle,Kathy-Ann Secker,Anita Schmitt,Hildegard Keppeler,Corina Schneidawind, Michael Schmitt,Dominik Schneidawind

BONE MARROW TRANSPLANTATIONno. SUPP1 (2023): 226-226

引用0浏览0引用

CRISPR/Cas9-induced expression of BCR/ABL1 is not sufficient to immortalize BM-derived HSPCs in vitro

P. Radszuweit,F. Korkmaz,B. Mankel,R. Fitzel,E. Erkner,H. Keppeler,C. Lengerke,D. Schneidawind,C. Schneidawind

ONCOLOGY RESEARCH AND TREATMENT (2023): 278-279

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn